Tonix Pharmaceuticals Announces Potential Positive Impact of the U.S. National Academies (NASEM) New Definition of Long COVID on the Size of the Fibromyalgia Market for Tonmya™
July 31, 2024 08:00 ET
|
Tonix Pharmaceuticals Holding Corp.
Fibromyalgia is a “diagnosable condition” in people suffering from Long COVID according to NASEM1 Diagnosing fibromyalgia in Long COVID patients is expected to expand the potential...
Avalon’s Laboratory Services MSO Launches DNA Testing Kit for Predisposition to Opioid Addiction
July 31, 2024 08:00 ET
|
Avalon GloboCare Corp.
FREEHOLD, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative cell-based technology, cellular therapy and precision...
Bipartisan Senate Bill Seeks to Clarify that Implanted Active Middle Ear Hearing Devices are Prosthetics, Not Hearing Aids, Making Them Eligible for Medicare Coverage
July 31, 2024 08:00 ET
|
Envoy Medical, Inc
Envoy Medical’s FDA-Approved Esteem® Fully Implanted Active Middle Ear Hearing Device May Now Have an Opportunity to be a Coverable Benefit WHITE BEAR LAKE, Minnesota, July 31, 2024 (GLOBE...
CareCloud To Announce Second-Quarter 2024 Results on August 13, 2024
July 31, 2024 08:00 ET
|
CareCloud, Inc
SOMERSET, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology and generative AI solutions for medical practices and health systems...
TTM Technologies, Inc. Reports Second Quarter 2024 Results
July 31, 2024 08:00 ET
|
TTM Technologies, Inc.
SANTA ANA, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- TTM Technologies, Inc. (NASDAQ: TTMI), a leading global manufacturer of technology solutions including mission systems, radio frequency (“RF”)...
IMUNON Announces $10 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
July 31, 2024 08:00 ET
|
Imunon, Inc.
LAWRENCEVILLE, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, today announced that it...
Rezolute to Participate in the BTIG Virtual Biotechnology Conference
July 31, 2024 08:00 ET
|
Rezolute, Inc.
REDWOOD CITY, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage biopharmaceutical company committed to developing novel,...
electroCore to Announce Second Quarter June 30, 2024 Financial Results on Wednesday, August 7, 2024
July 31, 2024 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial...
Bionano to Report Second Quarter 2024 Financial Results and Host a Conference Call and Webcast on August 7, 2024
July 31, 2024 08:00 ET
|
Bionano Genomics
SAN DIEGO, July 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, August 7, 2024, at 4:30 p.m....
Liquidia Corporation to Report Second Quarter 2024 Financial Results on August 7, 2024
July 31, 2024 08:00 ET
|
Liquidia Corporation
Liquidia Corporation to report second quarter 2024 financial results on
August 7, 2024.